Stable Istotope Labelled Clivatuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade

Reference: PX-TA1390-SIL-1MG
Product nameStable Istotope Labelled Clivatuzumab Biosimilar - Anti-MUC1/CD227 mAb - Research Grade
SourceCAS 1462876-11-4
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymshPAM4,hPAM4 IgG-DOTA,hPAM4-DOTA
ReferencePX-TA1390-SIL
Related ProductsPX-P4727
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-MUC1/CD227[Homo sapiens] (Clivatuzumab) Monoclonal Antibody

Clivatuzumab is investigated for the treatment of Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Clivatuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below